OMCL: Reading the Tea Leaves: COO's Promotion to President Adds Weight to CEO Succession Narrative

Research evidence excerpt

OMCL: Reading the Tea Leaves: COO's Promotion to President Adds Weight to CEO Succession Narrative

Equity Research

Flash Comment — July 1, 2026

Healthcare Technology

Omnicell Inc.

Reading the Tea Leaves: COO's Promotion to President Adds Overweight

Weight to CEO Succession Narrative Price Target: $55.00

Ticker OMCL

Our Call Upside/(Downside) to Target 28.0%

We think COO Njoku is being positioned as successor to CEO Lipps based on an evolving Price (07/01/2026) $42.96

mosaic including Njoku's expanded investor-facing presence and promotion to President 52 Week Range $26.85 - 55.00

entailing shaping Omnicell's long-term growth strategy and innovation roadmap. Market Cap (MM) $1,974

Source: Company Data, Wells Fargo Securities estimates, and Factset.

Initial Thoughts NA = Not Available, NC = No Change, NE = No Estimate

COO Nnamdi Njoku promoted to President. This morning, Omnicell appointed Nnamdi Stan Berenshteyn, CFA

Njoku President, effective July 1, while he retains the COO role and Randall Lipps remains Equity Analyst | Wells Fargo Securities, LLC

Stan.Berenshteyn@wellsfargo.com | 732-266-3756

CEO & Chairman. The move gives Njoku a broader hand in long-term strategy, innovation

and global operations, including Titan XT and OmniSphere. Corey DeVito

Associate Equity Analyst | Wells Fargo Securities, LLC

Corey.DeVito@wellsfargo.com | 212-214-5444

Details from our recent NDR. Our June NDR (note here) with CFO Radford left

us incrementally bullish on OMCL’s multi-year growth acceleration setup. Radford

underscored that he and COO Njoku ring-fenced spending around Titan XT, OmniSphere,

and the internal Salesforce, alongside cost containment and product rationalization.

The message reflected a strong collaboration between the CFO and COO reinvesting